Pulmonx Corporation logo

Pulmonx Corporation

NASDAQ:LUNG

Overview | Financials
Company Name Pulmonx Corporation
Symbol LUNG
Currency USD
Price 7.31
Market Cap 286,205,506
Dividend Yield 0%
52-week-range 5.46 - 14.835
Industry Medical Devices
Sector Healthcare
CEO Mr. Glendon E. French
Website https://pulmonx.com

An error occurred while fetching data.

About Pulmonx Corporation

Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system

Related Stocks

Editas Medicine, Inc. logo

Editas Medicine, Inc.

EDIT

3.59 USD

Theravance Biopharma, Inc. logo

Theravance Biopharma, Inc.

TBPH

8.01 USD

Deciphera Pharmaceuticals, Inc. logo

Deciphera Pharmaceuticals, Inc.

DCPH

25.59 USD

Replimune Group, Inc. logo

Replimune Group, Inc.

REPL

10.37 USD

Catalyst Pharmaceuticals, Inc. logo

Catalyst Pharmaceuticals, Inc.

CPRX

19.6 USD

IGM Biosciences, Inc. logo

IGM Biosciences, Inc.

IGMS

9.31 USD

Erasca, Inc. logo

Erasca, Inc.

ERAS

2.86 USD

TG Therapeutics, Inc. logo

TG Therapeutics, Inc.

TGTX

22.03 USD

DocGo Inc. logo

DocGo Inc.

DCGO

3.63 USD

Financials

Numbers are in millions USD

Numbers are in millions USD